Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heii Arai

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Suggestions Obtained from the J-CATIA Study (Japan Consortium for Antipsychotics Treatment in Alzheimer's Disease)]Heii Arai
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 23, 2010
[Immunotherapy and Alzheimer's disease]Heii Arai
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 6, 2011
[Clinical issues of younger patients with dementia--Japan Psychogeriatric Society]Heii Arai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2016
[A real-world survey on antipsychotic treatment for BPSD]Heii Arai
Cureus|November 24, 2025
Underestimated Centiloid Values in Amyloid PET: A Technical Report on Clinically Relevant Quantification ErrorsHeii Arai
Cureus|December 15, 2025
MRI-Based Medial Temporal Atrophy May Reflect Amyloid PET Positivity in Cognitively Normal Individuals: A Preliminary StudyHeii Arai
Case Reports in Psychiatry|July 23, 2015
Genetic or Psychogenic? A Case Study of "Folie à Quatre" Including TwinsTohru Ohnuma, Heii Arai
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in JapanHiroyuki Kobayashi, Heii Arai
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 11, 2010
Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophreniaTohru Ohnuma, Heii Arai
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortexTohru Ohnuma, Toshihito Suzuki, Heii Arai
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Suggestions Obtained from the J-CATIA Study (Japan Consortium for Antipsychotics Treatment in Alzheimer's Disease)]Heii Arai
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 23, 2010
[Immunotherapy and Alzheimer's disease]Heii Arai
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 6, 2011
[Clinical issues of younger patients with dementia--Japan Psychogeriatric Society]Heii Arai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2016
[A real-world survey on antipsychotic treatment for BPSD]Heii Arai
Cureus|November 24, 2025
Underestimated Centiloid Values in Amyloid PET: A Technical Report on Clinically Relevant Quantification ErrorsHeii Arai
Cureus|December 15, 2025
MRI-Based Medial Temporal Atrophy May Reflect Amyloid PET Positivity in Cognitively Normal Individuals: A Preliminary StudyHeii Arai
Case Reports in Psychiatry|July 23, 2015
Genetic or Psychogenic? A Case Study of "Folie à Quatre" Including TwinsTohru Ohnuma, Heii Arai
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in JapanHiroyuki Kobayashi, Heii Arai
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 11, 2010
Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophreniaTohru Ohnuma, Heii Arai
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortexTohru Ohnuma, Toshihito Suzuki, Heii Arai
Pageof 21